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Abstract 
Background  The effectiveness of psychosocial interventions in community mental 
healthcare has been shown to depend on the setting in which they are implemented. 
Recently structured patient-clinician communication was found to be effective in a 
multi-centre trial in six European countries, the DIALOG trial. In the overall study 
differences between centres were controlled for, not studied. Here we test whether the 
effectiveness of structured patient-clinician communication varies between services in 
different countries, and explore setting characteristics associated with outcome. 
Methods  The study is part of the DIALOG trial, which included 507 patients with 
schizophrenia or related disorder, treated by 134 keyworkers. The keyworkers were 
allocated to intervention or treatment as usual.  
Results  Positive effects were found on quality of life (Effect Size 0.20: 95%CI 0.01–
0.39) and treatment satisfaction (0.27: 0.06–0.47) in all centres, but reductions in 
unmet needs for care were only seen in two centres (-0.83 and -0.60), and in positive, 
negative and general symptoms in one (-0.87; -0.78; -0.87). The intervention was 
most effective in settings with patient populations with many unmet needs for care 
and high symptom levels. 
Conclusions  Psychosocial interventions in community mental healthcare may not be 
assumed to have uniform effectiveness across settings. Differences in patient 
population served and mental healthcare provided, should be studied for their 
influence on the effectiveness of the intervention. Structured patient-clinician 
communication has a uniform effect on quality of life and treatment satisfaction, but 
on unmet needs for care and symptom levels its effect differs between mental 
healthcare settings. 
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Introduction 
 
Established psychosocial interventions for people with severe mental illness, such as 
assertive community treatment [1, 2] and supported employment [3, 4], have been 
found to have non-uniform effectiveness across mental healthcare settings. This may 
be because settings differ in crucial aspects, such as patient selection or the ‘treatment 
as usual’ offered in the comparison condition of a trial, i.e. characteristics that are 
often left unspecified in research reports [5]. Alternatively, interventions may be 
perceived and appreciated differently in different cultures [6]. Burns and Catty [4] 
conclude that such differences in effectiveness of an intervention between settings 
may be as informative – e.g. with respect to understanding the mechanisms behind the 
effects – as their similarities, and that they should be studied rather than being treated 
as a complexity to be overcome. 
    Recently the effectiveness of a novel intervention – structured patient-clinician 
communication – was studied across six European community mental healthcare 
settings, in the DIALOG trial [7]. This showed that two-monthly, computer-assisted 
discussions between the patient and clinician of the patient’s satisfaction with 
different domains of life, current treatment, and needs for additional or different help, 
had a positive influence on the patient’s quality of life, unmet needs for care and 
treatment satisfaction. In the report by Priebe et al. [7] the six sites in which the trial 
was conducted, were treated as a random sample of all possible community mental 
healthcare settings that treat the target group of patients. Thus, study site was 
considered a random variable, that was treated as a ‘nuisance’ variable to be 
controlled for in the analysis, rather than being studied for its influence on the 
effectiveness of the intervention. 
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    The DIALOG intervention was intended to foster a ‘partnership model of care’ 
between patients and their clinicians, and to encourage patients to take an active role 
in care planning [8]. However, preference to participate in medical decision making is 
not universal across cultures [9, 10], and has been found to depend on age, gender, 
education, and social class [11, 12]. Therefore, universal effectiveness of the 
DIALOG intervention may not be assumed, but should be tested.  
 
■ Aims of the study 
We aim to test whether the effectiveness of the DIALOG intervention varies across 
mental healthcare settings in different countries, and to explore whether the 
effectiveness is associated with characteristics of the patient population served and the 
mental healthcare provided. The objective is to identify favourable and less 
favourable settings for the implementation of structured patient-clinician 
communication in community mental healthcare. 
 
 
Method 
 
■ Study design 
The present study is part of the DIALOG trial, which consisted of a cluster 
randomized controlled trial in community mental health services in six European 
countries. Eligible were services that provided comprehensive, outpatient care for 
people with schizophrenia or related psychotic disorders, and that operated a 
keyworker system in which every patient has a designated clinician. Keyworkers were 
randomly assigned to either the intervention of structured patient-clinician 
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communication or treatment as usual. The effect of the intervention was evaluated 
over a 1-year period, by pre and post interviews with the patients. Details of the 
randomization procedure and the eligibility criteria for keyworkers and patients have 
been provided by Priebe et al. [7]. The study was approved by relevant ethics 
committees in the six countries, and written informed consent was obtained from all 
keyworkers and patients.  
 
■ Intervention 
Keyworkers in the control group continued with standard treatment with their 
participating patients. In the intervention group keyworkers added the experimental 
intervention to standard treatment. The intervention consisted of a computer mediated 
procedure that the keyworker administered every two months in routine meetings with 
participating patients. The procedure specified that keyworkers asked their patients to 
rate their satisfaction with 11 domains of life or treatment, followed by the question 
whether patients wanted any additional or different help in the given domain. 
Patients’ answers were entered directly onto a (hand-held) computer. This enabled 
keyworkers and patients to immediately display and evaluate a response on a domain 
in the context of the responses on all other domains and in comparison with ratings at 
previous meetings. The intervention was designed to alter patient-keyworker 
interactions, so that the patient’s views of their life and treatment and their needs for 
care would become a central point for the dialogue between patient and clinician and 
inform all treatment discussions. Recently the intervention has been incorporated in a 
routine evaluation method in first episode psychosis services in London  [13]. 
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■ Outcomes 
Primary outcome was the patient’s subjective quality of life at the 12 months follow-
up assessment, controlling for the score at baseline. Quality of life was assessed with 
the Manchester Short Assessment of Quality of Life (MANSA) [14], in which 
patients rate their satisfaction with life in general and different life domains on 7-point 
scales ranging form ‘couldn’t be worse’ to ‘couldn’t be better’. The mean score on all 
satisfaction ratings is taken as the indicator for subjective quality of life. 
    Secondary outcomes were number of unmet needs for care and patient satisfaction 
with treatment. Needs for care were measured with the Camberwell Assessment of 
Need Short Appraisal Schedule, patient version (CANSAS)  [15, 16], which assesses 
health and social needs across 22 domains, as perceived by the patient. For each 
domain it distinguishes between ‘no need’, ‘met need’ and ‘unmet need’. Patient’s 
satisfaction with treatment was assessed on the Client Satisfaction Questionnaire 
(SCQ-8) [17], which consists of eight items rated from 1 to 4, with higher scores 
indicating greater treatment satisfaction. The total number of unmet needs for care 
and the sum score of satisfaction ratings at 12 months were studied as secondary 
outcomes, controlling for baseline scores. 
    The DIALOG intervention was hypothesized to increase subjective quality of life 
and satisfaction with treatment, and to reduce the number of unmet needs for care [7]. 
In addition, the influence of the intervention on psychiatric symptomatology was 
explored, but no effect was anticipated [7]. Symptomatology was assessed at baseline 
and 12 months follow-up with the Positive and Negative Syndrome Scale interview 
(PANSS) [18], which assesses positive, negative and general symptoms of 
schizophrenia on 7-point scales, with higher scores indicating more severe symptoms. 
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The total scores on the three subscales at 12 months were taken as separate outcome 
measures of psychiatric symptomatology, controlling again for baseline scores. 
 
■ Mental healthcare settings 
The DIALOG trial was conducted in community mental healthcare services in 
Granada (Spain), Groningen (the Netherlands), London (United Kingdom), Lund 
(Sweden), Mannheim (Germany), and Zürich (Switzerland), covering urban and 
mixed urban-rural areas. The number of participating teams per centre varied between 
two (Lund) and six (London). 
    In the exploratory analysis of correlates of difference in effectiveness of the 
DIALOG intervention between centres, centre characteristics with respect to patient 
group served and mental healthcare provided, will be studied. The patient group 
characteristics include (1) mean age, (2) gender distribution, (3) main diagnostic 
categories, (4) number of years in mental healthcare, (5) number of admissions to 
mental health clinics, and (6) level of functioning of the patient group. The mental 
healthcare characteristics consist of (7) mean caseload of keyworkers, (8) number of 
years in current job of keyworker, (9) number of face to face contacts per month per 
patient, (10) duration of these contacts, (11) duration of all care provided to a patient 
per month, and (12) number of meetings during the follow-up period in which the 
DIALOG intervention was administered in the intervention group. 
    The demographic characteristics of the patients, the number of years since first 
contact with mental healthcare and the number of hospital admissions (the above 
centre characteristic 1, 2, 4 and 5) were taken from the baseline patient interview of 
the DIALOG trial. Psychiatric diagnosis (centre characteristic 3) was obtained 
through a standardized and computer-based method using operationalized criteria 
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(OPCRIT) [19], which were checked in the patient’s medical record. Eligible for the 
DIALOG trial were patients with a primary diagnosis of schizophrenia or related 
psychotic disorder (ICD-10 F20–F29) [7], who were grouped for the present study 
into the categories schizophrenia (F20.0–F20.5), schizoaffective disorders (F25), and 
other psychotic disorders (rest). The mean level of functioning of the patient group 
(centre characteristic 6) was assessed by the mean baseline scores on quality of life, 
number of unmet needs for care, satisfaction with treatment, and symptomatology of 
the patients participating in the DIALOG trial. These variables were not combined, 
but were analyzed as separate indicators of the level of functioning of the patient 
group served. 
    Characteristics of the mental healthcare provided in the centres were obtained from 
interviews with the keyworkers who participated in the DIALOG trial. At baseline the 
keyworkers were asked about their total case load size and number of years in the 
current job (centre characteristics 7 and 8). The number and duration of face to face 
contacts per patient in the previous two months and the total duration of care per 
patient (centre characteristics 9 to 11) were assessed for the DIALOG patients, in an 
interview with their keyworker, 8 months after the patient’s baseline assessment. 
Finally, the (hand-held) computers used in the DIALOG intervention registered the 
number of times the intervention was administered during the follow up period in the 
intervention group (characteristic 12). 
    It should be noted that the above centre characteristics (with the exception of 
characteristics 7 and 8) only refer to the patients included in the DIALOG trial. This 
enables comparison between the study centres. But on the other hand, it does not 
show that all participating community mental health centres served a broader 
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population of severely mental ill patients, not just the patients with schizophrenia or 
related psychotic disorders who were eligible for the DIALOG trial.  
 
■ Analysis 
Differences between centres in the effectiveness of the DIALOG intervention are 
tested per outcome measure by linear mixed effects analysis, with baseline score for 
that measure, length of follow-up, treatment allocation, study centre and interaction 
between treatment allocation and study centre as fixed effects, and keyworker as 
random effect. Length of follow-up was also taken into account by Priebe et al. [7], 
because it is a potentially confounding covariate, that might have introduced post-
randomization variance. Keyworker is included in the analysis as a random effect, to 
adjust for the effect of clustering of patients within keyworkers. Effects are tested at a 
significance level of .05. Standardized effect sizes and their 95% confidence intervals 
will be presented for statistically significant effects, in the form of adjusted mean 
differences between factor levels, standardized by the within subjects standard 
deviation. 
    Differences between centres in patient group and mental healthcare characteristics 
will be tested by oneway analysis of variance, at a .05 significance level, and 
subsequently by pairwise comparisons between centres, using the Bonferroni 
correction for multiple testing. Significant differences will be discussed and explored 
for their associations with any main centre effect or interaction between centre and 
treatment allocation. 
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Results 
 
■ Participants 
Participants in the DIALOG trial consisted of 507 patients of 134 keyworkers. At the 
12 months follow-up assessment, 451 patients were reinterviewed (89% follow-up). A 
detailed description of participant flow from recruitment to data analysis has been 
presented by Priebe et al. [7]. 
 
■ Centre differences 
Table 1 here Table 1 shows the characteristics of the participating centres in the DIALOG trial, 
with respect to patient group served and mental healthcare provided. The centres 
differ on all characteristics studied, except on the age and gender distributions of their 
patient populations. In Groningen and Zürich fewer patients are diagnosed as having 
schizophrenia than in the other centres, and more as having a psychotic disorder other 
than schizophrenia or a schizoaffective disorder. The patients in Granada and London 
have a relatively brief history in mental healthcare, with fewer hospital admissions, 
while the patients in Mannheim and Lund had a larger number of hospital admissions. 
    The comparison of patient functioning at the baseline assessment of the DIALOG 
trial shows that patients in Mannheim and Zürich experience a relatively high quality 
of life, and that in Mannheim the number of unmet needs for care is low. In contrast, 
patients in London and Granada have comparatively more unmet needs for care. 
Nevertheless, treatment satisfaction is highest in Granada, and lowest in Groningen. 
Patients in London and Groningen experience the most positive, negative and general 
symptoms, and the patients in Lund and Granada the least. 
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    Outpatient mental healthcare for the patients with severe mental illness studied, is 
characterized in Zürich and Groningen by keyworkers with relatively high caseloads, 
who are not in their current position for very long. The latter is also true for 
keyworkers in London. The amount of treatment time per patient is greatest in 
Mannheim and Lund. In Mannheim this is because keyworkers have very frequent 
contacts with their patients, in Lund because the contacts are relatively long. The 
latter is also true for patient contacts in Groningen. Treatment time per patient is least 
in Granada and London, where the patient-keyworker contacts are relatively brief. In 
Granada also the number of contacts is low. Here, most patients only see their 
keyworker once every two months. This may explain why the patients in Granada had 
the lowest number of contacts over the follow-up period in which the DIALOG 
intervention was administered. 
 
■ Differences in effectiveness of the DIALOG intervention 
Table 2 here Differences between mental healthcare centres in the effectiveness of the DIALOG 
intervention are found for the outcomes unmet needs for care and general symptoms 
(Table 2). In addition, marginally significant interaction effects are found for positive 
and negative symptoms. The effects of the intervention on quality of life and 
treatment satisfaction, on the other hand, are uniform across centres. For treatment 
satisfaction also a centre effect is found, which means that – apart from the difference 
between the experimental and control group – also within these groups consistent 
differences between centres exist.  
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■ Effect sizes 
Table 3 here Table 3 presents the standardized sizes of the effects found. The uniform effects of the 
DIALOG intervention on quality of life (0.20; 95% CI: 0.01 – 0.39) and treatment 
satisfaction (0.27; 0.06 – 0.47) are small, which is consistent with the original study 
report by Priebe et al. [7]. However, the present study shows that the DIALOG 
intervention does not have a uniform effect on unmet needs for care, but that this 
effect depends on the centre in which the intervention is implemented. A large 
reduction in unmet needs is seen in London (-0.83; -1.29 – -0.36), and Granada (-
0.60; - 1.19 – -0.02), while in the other centres no clear effect on unmet needs is 
found. In London there is also a large reduction in general symptoms (-0.87; -1.39 – -
0.34), which – based on marginally significant interactions – is also seen for positive 
and negative symptoms in London (-0.87; -1.36 – -0.39, and -0.78; -1.31 – -0.26, 
respectively), but not in the other centres. These other centres show no effect of the 
DIALOG intervention on symptoms, as reported by Priebe et al. [7] for the study as a 
whole.  
    In addition to the intervention effects, centre effects are found on treatment 
satisfaction and positive and negative symptoms. On top of the uniform intervention 
effect on treatment satisfaction, patients in Granada – both in the experimental and 
control group – show a more favourable development over the follow-up period than 
the patients in the other centres (p<.01 on all pairwise comparisons). And when the 
marginally significant interactions between intervention and centre on positive and 
negative symptoms are disregarded: (1) patients in Granada, Groningen and Lund are 
found to experience a greater decrease in positive symptoms than patients in London, 
as is true for patients in Lund compared to patients in Mannheim and Zürich, and (2) 
patients in Granada and Lund experience a greater decrease in negative symptoms 
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than patients in London, Mannheim and Zürich, as is true for patients in Groningen 
compared to patients in Zürich (p<.05 on all pairwise comparisons), irrespective of 
the study group they were in. 
 
■ Association between effectiveness and centre characteristics 
Apart from the uniform effectiveness of the DIALOG intervention on quality of life 
and treatment satisfaction, the intervention proved to be effective on symptomatology 
in London and on number of unmet needs for care in London and Granada. Table 1 
shows that of all centres, the patients in London experienced the most positive, 
negative, and general symptoms at baseline, as well as the most unmet needs for care, 
with the patients in Granada being second on unmet needs for care. This suggests that 
the effectiveness of the DIALOG intervention on symptomatology and unmet needs 
for care may be associated with the baseline level of functioning on these aspects, in 
such a way that the intervention is more effective in patient groups with more 
symptoms, or more unmet needs for care. On the patient group level, the correlation 
between the mean level of functioning at baseline in a centre (as reported in table 1) 
and the effect size of the intervention in that centre on that aspect of functioning (as 
reported in table 3) is -0.46 for positive symptoms, -0.32 for negative symptoms, -
0.61 for general symptoms, and -0.92 for number of unmet needs for care (n=6). All 
these correlations indicate a stronger effectiveness of the intervention (i.e. a greater 
reduction in symptoms or unmet needs for care) in centres with patient groups that 
function more poorly at baseline (i.e. that have more symptoms or more unmet needs 
for care). On the individual patient level – in linear mixed effects models that do not 
take the centre into account – significant interactions between the baseline level of 
functioning and the intervention effect on level of functioning at follow-up are found 
 16 
for positive symptoms (F=4.69; p=.03), general symptoms (F=4.89; p=.03), and 
unmet needs for care (F=4.53; p=.03), but not for negative symptoms (F=0.18; p=.67). 
Again, these interactions are all in the direction of a greater intervention effect for 
patients with a poorer level of baseline functioning. 
    Besides their relatively high number of psychiatric symptoms at baseline and unmet 
needs for care, the patient groups in London and Granada also stand out for their 
somewhat shorter history in mental healthcare and fewer hospital admissions, than the 
patients in the other centres. In addition, the care the patients in London and Granada 
receive from their keyworkers, is comparatively limited in duration. As for the 
baseline level of functioning, these latter patient and care characteristics are also 
correlated on a patient group level with the outcomes that showed non-uniform 
effectiveness of the intervention between centres (range .26–.88; n=6). All of these 
correlations indicate more effectiveness of the intervention (i.e. a greater reduction in 
symptoms or unmet needs for care) in centres with patients who – on average – have a 
shorter history in mental healthcare and fewer hospital admissions, or in which the 
keyworkers have less time per patient for care. But on the individual patient level, a 
significant influence of the patient or care characteristic on intervention effectiveness 
was found in only on one of the twelve interactions tested: a greater reduction in 
unmet needs for care is seen in patients with a shorter history in mental healthcare 
(F=3.24; p=.07). The present study, therefore, provides more extensive empirical 
support for the assertion that the effectiveness of the DIALOG intervention on unmet 
needs for care and symptomatology is related to the baseline level of functioning of 
the patients on these outcomes, than for the idea that it would be related to the number 
of years the patients are in mental healthcare, the number of times they have been 
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admitted to hospital, or the amount of time their keyworkers are able to spend on their 
care.  
 
 
Discussion 
  
The present study shows that the effectiveness of the DIALOG intervention is not 
uniform across mental healthcare settings. It has a uniform effect on quality of life 
and patient satisfaction with treatment, as reported by Priebe et al. [7]. But on unmet 
needs for care and symptomatology its effect differs between mental healthcare 
settings. The intervention is most effective in settings with patient populations that 
function poorly on these outcomes. 
    An association between baseline level of functioning and patient outcome of the 
DIALOG intervention was also reported by Priebe et al. [7]. They found stronger 
effects on quality of life and unmet needs for care, when patients who were already 
positive about their quality of life and had less than two unmet needs for care at 
baseline, were excluded from the analyses. This was interpreted as an indication for a 
ceiling effect for baseline level of quality of life, respectively a floor effect for 
baseline number of unmet needs for care.  
    Hansson et al. [20] also studied the relationship between patient characteristics and 
the effectiveness of the DIALOG intervention. They found that no characteristic was 
related to the intervention effect on all patient outcomes. But on specific outcomes the 
intervention proved to be more effective for patients who were either older, in 
competitive employment, had a shorter duration of illness, or were more satisfied at 
baseline with their relationship with the keyworker. 
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    The analyses by Priebe et al. [7] and Hansson et al. [20] showed that – on an 
individual patient level – the effectiveness of the DIALOG intervention depends on 
the patient’s characteristics and baseline level of functioning. In the present analysis 
these influences were studied at a patient group level. In the centres in which the 
DIALOG intervention proved most effective (namely London and Granada), patients 
had comparatively high symptom levels (London), more unmet needs for care, a 
shorter history in mental healthcare and fewer hospital admissions (London and 
Granada). These findings are consistent with those of Priebe et al. [7] and Hansson et 
al. [20], in particular with the findings on the influence of baseline level of unmet 
needs for care [7] and duration of illness [20] on the effectiveness of the DIALOG 
intervention. Hanson et al [20] suggest that the intervention could be most beneficial 
to patients in a more acute phase of illness, because it may be harder for patients with 
a more chronic and longstanding illness to change their way of communicating with 
their clinician. 
    Does this mean that the DIALOG intervention should only be used in particular 
community mental healthcare patients – with particular characteristics or baseline 
levels of functioning – or that it should only be implemented in centres that serve 
many of these patients? We suggest not. Although the intervention did not reduce 
symptom levels and number of unmet needs for care in all centres (possibly due to a 
floor effect for unmet needs for care), it did improve treatment satisfaction and quality 
of life in all centres. Thus, the intervention appears to be uniformly beneficial to and 
appreciated by the patient groups, although it did not always improve their mental 
health to a measurable extent. The intended change in the patient-clinician 
relationship by the DIALOG intervention, towards a ‘partnership model of care’ and a 
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more active role of the patient in care planning [8], therefore seems to be valued 
across the different European cultures represented in the present study. 
    Alternatively, the differences between centres in the effectiveness of the DIALOG 
intervention may not be due to differences in patient population served, but to mental 
healthcare provided. London and Granada were also the centres with the least contact 
time between patient and keyworker. The DIALOG intervention may make a greater 
difference in care when the usual care is limited in time. For example, the intervention 
may increase the contact time with the keyworker, and this may make a greater 
difference in quality of care if the usual care is rather time constrained. But in the 
present study the effect of the DIALOG intervention on the quality of care was not 
evaluated. And the findings on the outcomes that were evaluated, namely aspects of 
patient functioning, do not point towards differences in care as the primary 
explanation for the differences in intervention effect observed. 
    Several limitations of the present study should be mentioned. First, it was 
undertaken post hoc, and variation in centre characteristics was therefore not 
systematically controlled. For example, the cultural differences between the 
participating centres were limited, as all were in western Europe. This reduces the 
power to detect differences in intervention effectiveness between centres, but as seen, 
the power was still adequate to show that the effectiveness is non-uniform, at least 
with respect to some outcomes. Second, the co-occurring characteristics of study 
centres – such as poor level of baseline functioning of patients, shorter illness 
duration, and limited contact time between patient and keyworker – compete as 
alternative explanations for the differences in effectiveness found, and circumstantial 
evidence is needed to weigh these explanations. A definitive answer can only be 
provided by testing the different explanations in new research. Finally, the integrity of 
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the implementation of the intervention was not controlled. For example, the 
intervention was administered less frequently in Granada than in other centres. And 
these differences in frequency and way of administering the intervention may 
influence the effectiveness of the intervention across centres. 
    Despite the above limitations, the present study is one of only a few studies testing 
the generalizability of the effectiveness of a psychosocial intervention across 
community mental healthcare settings. Differences in effectiveness were found. 
Structuring patient-clinician communication, to foster a ‘partnership model of care’ 
and a more active role of the patient in care planning, was found to be most effective 
in patient populations with higher symptom levels, more unmet needs for care, and a 
shorter duration of illness, and in services with limited patient-keyworker contact 
time. Nevertheless, the intervention was beneficial in all settings, as seen by the 
uniform positive effects on patient satisfaction with treatment and quality of life. 
Together these findings underline that uniform effectiveness of psychosocial 
interventions across community mental healthcare settings may not be assumed, but 
should be tested, and that this may be used for a better understanding of the 
mechanisms of community mental healthcare. 
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Table 1  Mental health centre characteristics 
 
Difference  Granada Groningen London Lund Mannheim Zürich 
F/Chi2 p 
Sample characteristics 
Patients participating in study 68 94 88 58 72 71   
Keyworkers 10 27 27 19 22 24   
 
Patient group characteristics 
Age, years [mean, (sd)] 39.6 (10.2) 41.9 (11.5) 42.3 (13.9) 42.4 (10.6) 43.5 (9.4) 44.2 (11.1) 1.35 .24 
Gender [% female] 30.9% 26.6% 35.2% 31.0% 30.6% 39.4% 3.61 .61 
Diagnosis 
  Schizophrenia 
  Schizoaffective disorder 
 Other psychotic disorder 
 
79.4% 
11.8% 
8.8% 
 
59.6% 
8.5% 
31.9% 
 
71.6% 
20.5% 
8.0% 
 
82.8% 
8.6% 
8.6% 
 
73.6% 
19.4% 
6.9% 
 
52.1% 
18.3% 
29.6% 
 
 
48.74 
 
 
 
<.001 
Years in mental healthcare 11.52 (7.29) 18.13 (9.94) 13.02 (10.89) 17.79 (10.94) 19.13 (9.21) 15.97 (9.95) 7.10 <.001 
Hospital admissions  2.14 (2.87) 4.81 (4.86) 3.07 (2.69) 8.33 (11.88) 9.33 (10.28) 4.69 (4.29) 12.10 <.001 
Baseline functioning 
 Quality of life 
 Treatment satisfaction 
 Number of unmet needs 
 Positive symptoms 
 Negative symptoms 
 General symptoms 
 
4.72 (0.82) 
27.56 (3.87) 
3.93 (2.70) 
14.18 (5.44) 
14.21 (5.57) 
26.59 (7.75) 
 
4.57 (0.72) 
24.18 (4.42) 
2.92 (2.60) 
15.69 (5.76) 
18.26 (6.38) 
36.31 (8.65) 
 
4.50 (0.82) 
25.24 (4.37) 
4.55 (3.48) 
16.15 (6.14) 
18.44 (6.74) 
36.58 (9.77) 
 
4.70 (0.96) 
25.07 (3.60) 
2.02 (2.17) 
12.36 (4.96) 
14.64 (6.45) 
26.69 (8.14) 
 
4.98 (0.80) 
26.01 (3.44) 
0.96 (1.42) 
14.89 (6.24) 
16.99 (7.41) 
33.21 (10.27) 
 
4.92 (0.94) 
26.90 (3.77) 
1.83 (2.16) 
14.87 (5.34) 
15.83 (6.34) 
31.75 (8.81) 
 
4.05 
7.60 
21.47 
3.71 
5.76 
17.90 
 
<.01 
<.001 
<.001 
<.01 
<.001 
<.001 
 
Care characteristics 
Caseload of keyworkera - 24.58 (9.60) 18.77 (7.38) 14.37 (8.40) 12.70 (12.51) 27.80 (13.37) 8.30 <.001 
Years keyworker in current jobb 12.22 (4.97) 5.42 (4.09) 4.74 (5.73) 10.95 (8.67) 11.43 (6.63) 4.65 (4.66) 6.96 <.001 
Face to face patient contacts 
 Median number of contacts last two monthsc 
 Duration per contact in minutes [mean, (sd)] 
 
1 (1) 
27.91 (8.59) 
 
3 (3) 
46.26 (20.68) 
 
3 (3) 
25.59 (16.59) 
 
6 (5) 
41.82 (17.85) 
 
10 (18) 
32.59 (20.36) 
 
4 (7) 
32.72 (15.76) 
 
44.16c 
15.31 
 
<.001 
<.001 
Median duration of patient care per monthc 30.0 (36.3) 95.0 (117.5) 50.0 (81.3) 112.5 (167.5) 196.5 (255.0) 75.0 (100.0) 33.70c <.001 
Number of DIALOG interventionsd 3.76 (1.44) 4.69 (1.31) 5.04 (1.51) 6.40 (1.33) 6.66 (0.69) 6.65 (0.69) 36.15 <.001 
 
a N= 0; 26; 22; 19; 20; 24 respectively, due to missing data 
b N= 9; 26; 23; 19; 20; 24 respectively, due to missing data 
c Median plus interquartile range and difference test for base-e logarithm of characteristic, because of skewness of distribution 
d For intervention group only
 Table 2  Intervention and mental health centre effects on outcomea 
 
Intervention effect 
 
Centre effect Interaction of 
Intervention and Centre 
Outcome 
F p F p F p 
Quality of life 4.19b .04 0.98 .43 0.51 .77 
Treatment satisfaction 6.77c .01 5.11c <.001 0.22 .96 
Unmet needs 3.39 .07 6.95 <.001 3.06 .01 
Positive symptoms 1.18 .28 3.58d <.01 2.24 .06 
Negative symptoms 0.48 .49 4.41d <.01 1.91 .10 
General symptoms 0.01 .92 3.36 <.01 2.71 .03 
 
a Full factorial model unless specified otherwise 
b In model with intervention effect only, because best fitting model 
c In model with centre and intervention effects only, because best fitting model 
d In model with centre effect only, because best fitting model 
 
Table 3  Standardized sizes of intervention and mental health centre effects 
Outcome 
(per Centre) 
Intervention effect 
 
Effect Size    (95% CI) 
p Centre effect 
 
Effect Size    (95% CI) 
p Intervention effect 
per Centre 
Effect Size    (95% CI) 
p 
 
Quality of life 
 
  
 0.20 (0.01 – 0.39) 
 
.04 
    
 
Treatment satisfaction 
 Granada 
 Groningen 
 London 
 Lund 
 Mannheim 
 Zürich 
 
 0.27 (0.06 – 0.47) 
 
 
.01 
 
 
0ab 
 -1.00 (-1.42 – -0.58) 
 -0.76 (-1.17 – -0.35) 
 -0.79 (-1.23 – -0.36) 
 -0.71 (-1.10 – -0.32) 
 -0.93 (-1.36 – -0.50) 
 
 
 
<.001 
<.001 
<.01 
<.01 
<.001 
  
Unmet needs 
 Granada 
 Groningen 
 London 
 Lund 
 Mannheim 
 Zürich 
   
 
 
 
 
 -0.60 (-1.19 – -0.02) 
 -0.28 (-0.73 – 0.17) 
 -0.83 (-1.29 – -0.36) 
 0.36 (-0.22 – 0.93) 
 0.18 (-0.33 – 0.69) 
 0.00 (-0.52 – 0.52) 
 
.04 
.23 
<.01 
.23 
.49 
.99 
Positive symptoms 
 Granada 
 Groningen 
 London 
 Lund 
 Mannheim 
 Zürich 
   
0a 
 0.11 (-0.35 – 0.57)c 
 0.50 (0.04 – 0.95)c 
 -0.22 (-0.71 – 0.28)c 
 0.37 (-0.07 – 0.81)c 
 0.44 (-0.05 – 0.92)c 
  
 0.06 (-0.56 – 0.69) 
 -0.03 (-0.51 – 0.45) 
 -0.87 (-1.36 – -0.39) 
 -0.07 (-0.68 – 0.53) 
 0.07 (-0.47 – 0.61) 
 0.11 (-0.44 – 0.66) 
 
.84 
.90 
<.01 
.81 
.80 
.68 
Negative symptoms 
 Granada 
 Groningen 
 London 
 Lund 
 Mannheim 
 Zürich 
   
0a 
 0.40 (-0.11 – 0.90)d 
 0.59 (0.09 – 1.08)d 
 0.03 (-0.51 – 0.56)d 
 0.63 (0.15 – 1.12)d 
 0.89 (0.37 – 1.42)d 
 
 
.12 
.02 
.92 
.01 
<.01 
 
 -0.28 (-0.99 – 0.42) 
 0.15 (-0.37 – 0.66) 
 -0.78 (-1.31 – -0.26) 
 0.21 (-0.45 – 0.86) 
 0.07 (-0.52 – 0.66) 
 0.13 (-0.47 – 0.73) 
 
.43 
.58 
<.01 
.53 
.81 
.67 
General symptoms 
 Granada 
 Groningen 
 London 
 Lund 
 Mannheim 
 Zürich 
     
 0.07 (-0.63 – 0.77) 
 0.01 (-0.50 – 0.53) 
 -0.87 (-1.39 – -0.34) 
 0.42 (-0.23 – 1.08) 
 0.32 (-0.26 – 0.91) 
 -0.04 (-0.64 – 0.55) 
 
.83 
.96 
<.01 
.20 
.27 
.89 
a Reference category 
b Granada higher than all other centres (p<.01, pairwise), no other differences between centres 
c Granada, Groningen and Lund lower than London, and Lund also lower than Mannheim and Zürich (p<.05, pairwise) 
d Granada and Lund lower than London, Mannheim and Zürich, and Groningen lower than Zürich (p<.05, pairwise) 
